These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6685807)

  • 1. Propranolol withdrawal-induced supersensitivity to the chronotropic effects of isoproterenol in the conscious rabbit.
    Tenner TE
    Life Sci; 1983 Dec; 33(23):2291-9. PubMed ID: 6685807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial sensitivity to isoproterenol following abrupt propranolol withdrawal in conscious dogs.
    Webb JG; Newman WH; Walle T; Daniell HB
    J Cardiovasc Pharmacol; 1981; 3(3):622-35. PubMed ID: 6168842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propranolol withdrawal supersensitivity in rat cardiovascular tissue, in vitro.
    Tenner TE
    Eur J Pharmacol; 1983 Aug; 92(1-2):91-7. PubMed ID: 6313393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of propranolol withdrawal phenomena.
    Nattel S; Rangno RE; Van Loon G
    Circulation; 1979 Jun; 59(6):1158-64. PubMed ID: 436208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemodynamic rebound phenomena after abrupt cessation of propranolol therapy in portal hypertensive rats.
    Lee SS; Braillon A; Girod C; Geoffroy P; Lebrec D
    J Hepatol; 1986; 3(1):38-41. PubMed ID: 3018073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of hypersensitivity to adrenergic stimulation after abrupt withdrawal of propranolol and nadolol: influence of half-life differences.
    Krukemyer JJ; Boudoulas H; Binkley PF; Lima JJ
    Am Heart J; 1990 Sep; 120(3):572-9. PubMed ID: 2389694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of withdrawal phenomena after propranolol, metoprolol, and pindolol.
    Rangno RE; Langlois S
    Am Heart J; 1982 Aug; 104(2 Pt 2):473-8. PubMed ID: 7102534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypersensitivity to adrenergic stimulation after propranolol withdrawal in normal subjects.
    Boudoulas H; Lewis RP; Kates RE; Dalamangas G
    Ann Intern Med; 1977 Oct; 87(4):433-6. PubMed ID: 199099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ex vivo examination of beta-adrenoceptor characteristics after propranolol withdrawal.
    Chess-Williams RG; Broadley KJ
    J Cardiovasc Pharmacol; 1984; 6(4):701-6. PubMed ID: 6206329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodynamic and metabolic response after abrupt uithdrawal of long-term propranolol.
    Myers JH; Horwitz LD
    Circulation; 1978 Aug; 58(2):196-201. PubMed ID: 566642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta adrenergically mediated cardiac chronotropic and vascular smooth muscle responses during propranolol therapy and withdrawal in young and elderly persons.
    Ford GA; Hoffman BB; Blaschke TF
    J Gerontol; 1992 Jan; 47(1):M22-6. PubMed ID: 1730849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical and physiological adaptation to chronic propranolol treatment in the rat.
    Cramb G; Griffiths NM; Aiton JF; Simmons NL
    Biochem Pharmacol; 1984 Jun; 33(12):1969-76. PubMed ID: 6329227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes of cyclic AMP concentration to isoproterenol after abrupt cessation of propranolol in rats.
    Kobayashi A; Ogawa K; Yamazaki N
    Jpn Heart J; 1980 May; 21(3):399-407. PubMed ID: 6249944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions between sympathomimetic agonists and blocking agents: cardiac effects of phenylephrine and isoproterenol.
    Márquez MT; Mikulić LE; Aramendía P
    Methods Find Exp Clin Pharmacol; 1981; 3(5):283-9. PubMed ID: 7329156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac hyper- and hyporesponsiveness after pindolol withdrawal.
    Rangno RE; Langlois S; Stewart J
    Clin Pharmacol Ther; 1982 May; 31(5):564-71. PubMed ID: 7075106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Withdrawal of beta-blocking drugs.
    Walden RJ; Hernandez J; Yu Y; Al-Khader A; Prichard BN
    Am Heart J; 1982 Aug; 104(2 Pt 2):515-20. PubMed ID: 6125098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adrenergic hypersensitivity after beta-blocker withdrawal in hypertrophic cardiomyopathy.
    Gilligan DM; Chan WL; Stewart R; Oakley CM
    Am J Cardiol; 1991 Sep; 68(8):766-72. PubMed ID: 1892084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of the safe withdrawal period for propranolol in patients scheduled for open heart surgery.
    Coltart DJ; Cayen MN; Stinson EB; Goldman RH; Davies RO; Harrison DC
    Br Heart J; 1975 Dec; 37(12):1228-34. PubMed ID: 1225337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of atropine, isoproterenol and propranolol on the rabbit bladder contraction induced by intra-arterial administration of acetylcholine and ATP.
    Liu SP; Horan P; Levin RM
    J Urol; 1998 Nov; 160(5):1863-6. PubMed ID: 9783975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased sensitivity to isoprenaline following digoxin pretreatment in anaesthetised and conscious dogs.
    Mihailidou AS; Einstein R; Richardson DP; Gray P; Jones MP; Hunyor SN
    Cardiovasc Res; 1990 Mar; 24(3):222-6. PubMed ID: 2346956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.